FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to derivatives of piperazine oxime of the general formula (I): wherein X means phenyl or pyridyl substituted with 1 or 2 substitutes; Y means 2- or 3-indolyl, phenyl, 7-azaindole-3-yl, 3-indazolyl, 2-naphthyl, 3-benzo[b]thiophenyl or 2-benzofuranyl that can be substituted; n = 0-3; m = 0-2; R1 means -NH2, morpholino-, thiomorpholino-group, 2-, 3- or 4-pyridyl or 4-CH3-piperazinyl. Compounds possess antagonistic activity with respect to neurokinine receptors and can be used in treatment of anxiety states. Also, invention describes a pharmaceutical composition based on compounds of the formula (I), method for its preparing and using.
EFFECT: valuable medicinal properties of compounds and composition.
7 cl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF DIAZABICYCLIC ALKANES ELICITING NK-ANTAGONISTIC ACTIVITY | 2003 |
|
RU2310656C2 |
HEXA- AND OCTAHYDROPYRIDO[1,2-a]PYRAZINE DERIVATIVES WITH NK-ANTAGONIST ACTIVITY | 2004 |
|
RU2349591C2 |
SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITION OF CATHEPSIN S ACTIVITY | 2001 |
|
RU2278863C2 |
DERIVATIVES OF AROYLPIPERAZINE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT | 1998 |
|
RU2258702C2 |
DERIVATIVES OF N-TRIAZOLYLMETHYLPIPERAZINE, METHOD FOR THEIR PREPARING, MEDICINAL AGENT, DERIVATIVES OF PIPERAZINE | 2001 |
|
RU2288918C2 |
APOPTOSIS INDUCING AGENTS SELECTIVE FOR Bcl-2 FOR CANCER AND IMMUNE DISEASES TREATMENT | 2013 |
|
RU2621052C2 |
APOPTOSIS-INDUCING PREPARATIONS FOR TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | 2009 |
|
RU2527450C2 |
BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR TREATING CANER AND IMMUNE DISEASES | 2010 |
|
RU2542994C2 |
INDOLES AS 5-HT MODULATORS | 2007 |
|
RU2449990C2 |
MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTERS | 2005 |
|
RU2528046C2 |
Authors
Dates
2006-04-10—Published
2002-07-03—Filed